Partanen J - Search Results

1

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P, Mustjoki S. Kreutzman A, et al. Among authors: partanen j. Exp Hematol. 2012 Nov;40(11):906-913.e1. doi: 10.1016/j.exphem.2012.07.007. Epub 2012 Jul 25. Exp Hematol. 2012. PMID: 22842045 Free article.

2

Global gene expression profile of human cord blood-derived CD133+ cells.

Jaatinen T, Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, Partanen J. Jaatinen T, et al. Among authors: partanen j. Stem Cells. 2006 Mar;24(3):631-41. doi: 10.1634/stemcells.2005-0185. Epub 2005 Oct 6. Stem Cells. 2006. PMID: 16210406

3

Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.

Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, Partanen J, Jaatinen T. Hemmoranta H, et al. Among authors: partanen j. Stem Cells Dev. 2006 Dec;15(6):839-51. doi: 10.1089/scd.2006.15.839. Stem Cells Dev. 2006. PMID: 17253947

4

Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.

Sivula J, Volin L, Porkka K, Vettenranta K, Itälä M, Partanen J, Turpeinen H. Sivula J, et al. Among authors: partanen j. Transpl Immunol. 2007 Jul;18(1):62-6. doi: 10.1016/j.trim.2007.03.006. Epub 2007 Apr 19. Transpl Immunol. 2007. PMID: 17584604

5

N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells.

Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O, Saarinen J, Natunen J, Partanen J, Laine J, Jaatinen T. Hemmoranta H, et al. Among authors: partanen j. Exp Hematol. 2007 Aug;35(8):1279-92. doi: 10.1016/j.exphem.2007.05.006. Exp Hematol. 2007. PMID: 17662891 Free article.

6

Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation.

Sivula J, Cordova ZM, Tuimala J, Jaatinen T, Partanen J, Volin L, Turpeinen H. Sivula J, et al. Among authors: partanen j. Scand J Immunol. 2012 Sep;76(3):336-41. doi: 10.1111/j.1365-3083.2012.02737.x. Scand J Immunol. 2012. PMID: 22703024 Free article.

7

Expression of fibroblast growth factor receptors in human leukemia cells.

Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R. Armstrong E, et al. Among authors: partanen j. Cancer Res. 1992 Apr 1;52(7):2004-7. Cancer Res. 1992. PMID: 1372535

We have previously cloned from K562 leukemia cells two novel fibroblast growth factor receptors (FGFR-3 and FGFR-4; J. Partanen et al., EMBO J., 10: 1347-1354, 1991). Here we have analyzed the mRNA expression of four different FGFRs, including the two novel g …

We have previously cloned from K562 leukemia cells two novel fibroblast growth factor receptors (FGFR-3 and FGFR-4; J. Partanen …

8

Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.

Alitalo R, Partanen J, Pertovaara L, Hölttä E, Sistonen L, Andersson L, Alitalo K. Alitalo R, et al. Among authors: partanen j. Blood. 1990 May 15;75(10):1974-82. Blood. 1990. PMID: 2159816 Free article.

9

Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2.

Huang TS, Hsieh JY, Wu YH, Jen CH, Tsuang YH, Chiou SH, Partanen J, Anderson H, Jaatinen T, Yu YH, Wang HW. Huang TS, et al. Among authors: partanen j. Stem Cells. 2008 May;26(5):1186-201. doi: 10.1634/stemcells.2007-0821. Epub 2008 Feb 28. Stem Cells. 2008. PMID: 18308945

10

Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients.

Impola U, Turpeinen H, Alakulppi N, Linjama T, Volin L, Niittyvuopio R, Partanen J, Koskela S. Impola U, et al. Among authors: partanen j. Front Immunol. 2014 Aug 25;5:405. doi: 10.3389/fimmu.2014.00405. eCollection 2014. Front Immunol. 2014. PMID: 25202311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page